Life Sciences

  • Share

Life Sciences transactions advisory services

EY - Find out how they can support the capital agenda of your portfolio company

Executing on the investment strategy

In today's market, the life sciences companies that can define a clear strategy, deploy capital effectively against that strategy and continue to innovate will win. Having the right advisors who understand your investment strategy, know your team, have the relevant transaction skills and industry knowledge and are ready when you are can help make the difference.EY - The Life Sciences Capital Agenda

How we can help

The Life Sciences Capital Agenda framework helps connect your overall capital strategy to our services as you focus on the cornerstones of preserving, optimizing, investing and raising capital. It also helps you consider capital options throughout the economic cycle. Choosing the right options will help you make the decisions needed to succeed in today's environment where volatility is the only constant.

Our transaction professionals understand and can help you execute the increasingly innovative transactions that are redefining the life sciences industry.

EY in the media

Connect with us

Stay connected with us through social media, email alerts or webcasts. Or download our EY Insights app for mobile devices.

EY - Capital Confidence Barometer: Life Sciences

Capital Confidence Barometer – life sciences

Confidence in an improving global economy is decreasing for biotech and pharma executives. Find out more in our 11th Capital Confidence Barometer.

EY - Firepower and growth gap report 2015

Firepower Index and Growth Gap Report 2015 - Firepower fireworks

As the dust settled in the waning days of the year’s end, EY took stock of the biopharma deals consummated in 2014 to understand the implications for the year ahead.